PLANDAI BIOTECHNOLOGY, INC. Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2016-03-31..
Quick ratio
Overview →Financial period ending 2016-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2016-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 15.44M USD | Liabilities, Current |
| Cash and equivalents | 7.96K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 48.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 54.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2016-03-31 | (m) | $15.44M | $7.96K | (m) | $48.00K | $54.00K | (m) |
| 2015-12-31 | (m) | $14.38M | $13.51K | (m) | $18.80K | $45.49K | (m) |
| 2015-09-30 | (m) | $14.80M | $5.56K | (m) | $14.92K | $6.22K | (m) |
| 2015-06-30 | (m) | $15.15M | $33.62K | (m) | $17.12K | $2.29K | (m) |
| 2015-03-31 | (m) | $8.36M | (m) | (m) | $7.03K | $3.50K | (m) |
| 2014-12-31 | (m) | $7.69M | (m) | (m) | $11.53K | $3.17K | (m) |
| 2014-09-30 | (m) | $289.17K | (m) | (m) | $12.26K | $2.20K | (m) |
| 2014-06-30 | (m) | $226.90K | (m) | (m) | $8.13K | $2.52K | (m) |
| 2014-03-31 | (m) | $557.89K | (m) | (m) | $6.36K | $3.27K | (m) |
| 2013-12-31 | (m) | $2.68M | (m) | (m) | $7.01K | $3.77K | (m) |
| 2013-09-30 | (m) | $819.73K | (m) | (m) | $12.33K | $5.15K | (m) |
| 2013-06-30 | (m) | $903.74K | (m) | (m) | $13.64K | $6.44K | (m) |
| 2013-03-31 | (m) | $680.40K | (m) | (m) | $11.52K | (m) | (m) |
| 2012-12-31 | (m) | $341.30K | (m) | (m) | $12.00 | (m) | (m) |
| 2012-09-30 | (m) | $179.36K | (m) | (m) | $28.13K | (m) | (m) |
| 2012-06-30 | (m) | $100.48K | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $320.94K | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $177.95K | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $6.46M | (m) | (m) | $665.55K | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | $702.20K | (m) | (m) |
| 2011-03-31 | (m) | $6.00M | $0.00 | (m) | $574.28K | (m) | (m) |
| 2010-09-30 | (m) | (m) | $23.00 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $40.00 | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | $7.43K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.